Sergiusz Jóźwiak

19.9k total citations · 4 hit papers
207 papers, 7.9k citations indexed

About

Sergiusz Jóźwiak is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Sergiusz Jóźwiak has authored 207 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Physiology, 55 papers in Molecular Biology and 46 papers in Oncology. Recurrent topics in Sergiusz Jóźwiak's work include Tuberous Sclerosis Complex Research (141 papers), Polyomavirus and related diseases (30 papers) and Histiocytic Disorders and Treatments (27 papers). Sergiusz Jóźwiak is often cited by papers focused on Tuberous Sclerosis Complex Research (141 papers), Polyomavirus and related diseases (30 papers) and Histiocytic Disorders and Treatments (27 papers). Sergiusz Jóźwiak collaborates with scholars based in Poland, United States and Italy. Sergiusz Jóźwiak's co-authors include Paolo Curatolo, Katarzyna Kotulska, Roberta Bombardieri, Elizabeth A. Thiele, David J. Kwiatkowski, Robert A. Schwartz, David Neal Franz, Dorota Domańska‐Pakieła, Elizabeth P. Henske and Penelope Roberts and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Sergiusz Jóźwiak

197 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tuberous sclerosis

2008 750 citations Paolo Curatolo, Sergiusz Jóźwiak et al. profile →
Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple Organs

2001 700 citations Sergiusz Jóźwiak, David Neal Franz et al. The American Journal of Human Genetics profile →
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

2012 578 citations David Neal Franz, Е. Д. Белоусова et al. profile →
Tuberous sclerosis complex

2016 457 citations Sergiusz Jóźwiak et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergiusz Jóźwiak Poland	42	5.4k	2.3k	2.1k	1.4k	1.1k	207	7.9k
David Neal Franz United States	44	6.0k 1.1×	2.6k 1.1×	2.5k 1.2×	1.6k 1.1×	1.5k 1.4×	135	9.1k
Hope Northrup United States	38	2.6k 0.5×	2.0k 0.9×	942 0.5×	1.5k 1.1×	493 0.5×	156	6.1k
Dicky Halley Netherlands	36	2.0k 0.4×	1.8k 0.8×	678 0.3×	1.6k 1.2×	714 0.7×	129	5.2k
Julian R. Sampson United Kingdom	41	2.0k 0.4×	3.0k 1.3×	2.6k 1.2×	1.5k 1.0×	820 0.8×	112	7.5k
Jeremy P. Cheadle United Kingdom	35	1.4k 0.3×	3.1k 1.3×	2.3k 1.1×	1.2k 0.9×	681 0.6×	76	6.5k
Mark Nellist Netherlands	31	2.1k 0.4×	1.4k 0.6×	871 0.4×	770 0.5×	303 0.3×	72	3.3k
Hans Scheffer Netherlands	47	583 0.1×	3.7k 1.6×	341 0.2×	2.7k 1.9×	567 0.5×	191	7.9k
Christine M. Eng United States	34	2.7k 0.5×	1.3k 0.6×	142 0.1×	1.9k 1.3×	234 0.2×	81	5.7k
M. Priscilla Short United States	34	1.1k 0.2×	1.5k 0.7×	591 0.3×	1.2k 0.8×	503 0.5×	55	4.2k
Joel Charrow United States	46	4.1k 0.8×	1.5k 0.7×	105 0.1×	664 0.5×	258 0.2×	143	7.1k

Countries citing papers authored by Sergiusz Jóźwiak

Since Specialization

Citations

This map shows the geographic impact of Sergiusz Jóźwiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergiusz Jóźwiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergiusz Jóźwiak more than expected).

Fields of papers citing papers by Sergiusz Jóźwiak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergiusz Jóźwiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergiusz Jóźwiak. The network helps show where Sergiusz Jóźwiak may publish in the future.

Co-authorship network of co-authors of Sergiusz Jóźwiak

This figure shows the co-authorship network connecting the top 25 collaborators of Sergiusz Jóźwiak. A scholar is included among the top collaborators of Sergiusz Jóźwiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergiusz Jóźwiak. Sergiusz Jóźwiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marcinkowska, Anna, et al.. (2024). Differences between Tuberous Sclerosis Complex Patients with and without Epilepsy: The Results of a Quantitative Diffusion Tensor Imaging Study. Biomedicines. 12(9). 2061–2061.

Jóźwiak, Sergiusz, et al.. (2023). Safety of Sirolimus in Patients with Tuberous Sclerosis Complex under Two Years of Age—A Bicenter Retrospective Study. Journal of Clinical Medicine. 12(1). 365–365. 7 indexed citations

Kotulska, Katarzyna, et al.. (2023). Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of Age. Neurology and Therapy. 12(3). 931–946. 12 indexed citations

Klonowska, Katarzyna, Krinio Giannikou, Aaron R. Thorner, et al.. (2023). Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex. The American Journal of Human Genetics. 110(6). 979–988. 19 indexed citations

Specchio, Nicola, Rima Nabbout, Eleonora Aronica, et al.. (2023). Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy. European Journal of Paediatric Neurology. 47. 25–34. 24 indexed citations

Jóźwiak, Sergiusz, Katarzyna Kotulska, E. Martina Bebin, & Darcy A. Krueger. (2023). Commentary Regarding the Results of the PREVeNT and EPISTOP Trials. Annals of Neurology. 95(1). 12–14. 3 indexed citations

Pawlik, Bartłomiej, Wojciech Fendler, Izabela Dróźdż, et al.. (2022). mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile. Journal of Clinical Medicine. 11(12). 3395–3395. 4 indexed citations

Pawlik, Bartłomiej, Wojciech Fendler, Izabela Dróźdż, et al.. (2022). MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor. International Journal of Molecular Sciences. 23(22). 14493–14493. 3 indexed citations

Marcinkowska, Anna, et al.. (2022). Tuberous sclerosis complex-associated neuropsychiatric disorders. Psychiatria Polska. 57(4). 823–842. 4 indexed citations

10.

Marcinkowska, Anna, et al.. (2022). Tuberous Sclerosis Complex Patients’ Needs and Difficulties—Results of TAND Questionnaire Analysis in Polish Adult Population. Journal of Clinical Medicine. 11(21). 6536–6536. 5 indexed citations

11.

Jóźwiak, Sergiusz, et al.. (2019). Long-term Outcome of Intravenous Lidocaine in Pediatric Cluster Seizures: A Preliminary Study. Pediatric Neurology. 97. 43–49. 1 indexed citations

12.

Mintz, Mark, J. Eric Piña-Garza, Steven M. Wolf, et al.. (2018). Safety and Tolerability of Adjunctive Eslicarbazepine Acetate (ESL) in Pediatric Patients (Aged 4–17 Years) with Partial-Onset (Focal) Seizures (POS) (P5.269). Neurology. 90(15_supplement).

13.

Krueger, Darcy A., Jamie K. Capal, Paolo Curatolo, et al.. (2018). Safety of mTOR Inhibitors in Infants with Tuberous Sclerosis Complex (TSC): Multicenter Clinical Experience (S35.003). Neurology. 90(15_supplement).

14.

Stawiski, Konrad, Joanna Trelińska, Katarzyna Kotulska, et al.. (2017). What are the true volumes of SEGA tumors? Reliability of planimetric and popular semi-automated image segmentation methods. Magnetic Resonance Materials in Physics Biology and Medicine. 30(4). 397–405. 7 indexed citations

15.

Franz, David Neal, Е. Д. Белоусова, Steven Sparagana, et al.. (2014). Everolimus Long-Term Efficacy and Safety for the Treatment of Subependymal Giant Cell Astrocytoma (SEGA) Associated With Tuberous Sclerosis Complex (TSC) (S42.007). Neurology. 82(10_supplement). 1 indexed citations

16.

Borkowska, Julita, Robert A. Schwartz, Katarzyna Kotulska, & Sergiusz Jóźwiak. (2010). Tuberous sclerosis complex: tumors and tumorigenesis. International Journal of Dermatology. 50(1). 13–20. 81 indexed citations

17.

Jóźwiak, Sergiusz, Aleksandra Habich, Katarzyna Kotulska, et al.. (2010). Intracerebroventricular Transplantation of Cord Blood-Derived Neural Progenitors in a Child with Severe Global Brain Ischemic Injury. PubMed. 1(2). 71–80. 36 indexed citations

18.

Tylki‐Szymańska, Anna, et al.. (2001). Rozpoznawanie zespołu Retta w oparciu o własne obserwacje w grupie 100 dziewczynek. 10(19). 1 indexed citations

19.

Verhoef, Senno, Tadeusz Mazurczak, Sergiusz Jóźwiak, et al.. (1999). High Rate of Mosaicism in Tuberous Sclerosis Complex. The American Journal of Human Genetics. 64(6). 1632–1637. 121 indexed citations

20.

Short, M. Priscilla, et al.. (1994). Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1. The American Journal of Human Genetics. 55. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact